Guggenheim Capital LLC Mirati Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $107,368 - $159,505	2,557 Added 8.27%	33,462 $1.97 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $89,015 - $145,210	3,202 Added 11.56%	30,905 $1.35 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $9,574 - $13,114	265 Added 0.97%	27,703 $1 Million
Q1 2023 May 10, 2023	SELL	$36.54 - $54.26 $653,152 - $969,897	-17,875 Reduced 39.45%	27,438 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $865,555 - $2.07 Million	20,973 Added 86.17%	45,313 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $450,415 - $656,319	-7,570 Reduced 23.72%	24,340 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $160,947 - $364,598	4,110 Added 14.78%	31,910 $2.14 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $262,943 - $523,563	3,468 Added 14.25%	27,800 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $453,718 - $654,026	3,437 Added 16.45%	24,332 $3.57 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $91,566 - $122,972	-693 Reduced 3.21%	20,895 $3.7 Million
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $79,488 - $99,210	552 Added 2.62%	21,588 $3.49 Million
Q1 2021 May 13, 2021	BUY	$158.92 - $221.61 $444,181 - $619,399	2,795 Added 15.32%	21,036 $3.6 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $483,071 - $716,244	-2,981 Reduced 14.05%	18,241 $4.01 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $1.21 Million - $1.78 Million	-10,656 Reduced 33.43%	21,222 $3.52 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $499,821 - $835,626	6,941 Added 27.83%	31,878 $3.64 Million
Q1 2020 Jun 02, 2020	SELL	$69.78 - $116.21 $514,906 - $857,513	-7,379 Reduced 22.83%	24,937 $1.92 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $2.29 Million - $4.16 Million	32,316 New	32,316 $4.16 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $199,449 - $280,576	-2,560 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $152,294 - $268,057	2,560 New	2,560 $263,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account